← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

SEER logoSeer, Inc.(SEER)Earnings, Financials & Key Ratios

SEER•NASDAQ
$1.89
$105M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryDiagnostics and Omics Tools
AboutSeer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.Show more
  • Revenue$14M-8.1%
  • EBITDA-$94M+5.5%
  • Net Income-$87M-0.4%
  • EPS (Diluted)-1.39-3.0%
  • Gross Margin48.99%+413.2%
  • EBITDA Margin-673.44%-2.9%
  • Operating Margin-717.72%-3.8%
  • Net Margin-620.91%-9.3%
  • ROE-23.91%-16.9%
  • ROIC-21.28%-10.4%
  • Debt/Equity0.08+11.3%
Technical→

SEER Key Insights

Seer, Inc. (SEER) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong 5Y sales CAGR of 160.6%
  • ✓Share count reduced 2.4% through buybacks
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SEER Price & Volume

Seer, Inc. (SEER) stock price & volume — 10-year historical chart

Loading chart...

SEER Growth Metrics

Seer, Inc. (SEER) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years160.62%
3 Years29.69%
TTM14.49%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM4%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-3.08%

Return on Capital

10 Years-21.06%
5 Years-19.32%
3 Years-22.94%
Last Year-25.86%

SEER Recent Earnings

Seer, Inc. (SEER) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 3/12 qtrs (25%)
Q1 2026Latest
Feb 26, 2026
EPS
$0.29
Est $0.32
+9.4%
Revenue
$4M
Est $5M
-8.7%
Q4 2025
Nov 6, 2025
EPS
$0.32
Est $0.32
+0.0%
Revenue
$4M
Est $5M
-10.4%
Q3 2025
Aug 6, 2025
EPS
$0.33
Est $0.39
+15.4%
Revenue
$4M
Est $4M
+8.0%
Q2 2025
May 13, 2025
EPS
$0.34
Est $0.37
+8.1%
Revenue
$4M
Est $4M
+3.8%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 26, 2026
$0.29vs $0.32+9.4%
$4Mvs $5M-8.7%
Q4 2025Nov 6, 2025
$0.32vs $0.32+0.0%
$4Mvs $5M-10.4%
Q3 2025Aug 6, 2025
$0.33vs $0.39+15.4%
$4Mvs $4M+8.0%
Q2 2025May 13, 2025
$0.34vs $0.37+8.1%
$4Mvs $4M+3.8%
Based on last 12 quarters of dataView full earnings history →

SEER Peer Comparison

Seer, Inc. (SEER) competitors in Diagnostics and Omics Tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
QTRX logoQTRXQuanterix CorporationDirect Competitor154.43M3.29-1.312.56%-71.92%-35.17%0.13
CDNA logoCDNACareDx, IncDirect Competitor1.08B20.94-52.3513.79%-1.98%-2.61%0.06
NAUT logoNAUTNautilus Biotechnology, Inc.Direct Competitor373.61M2.94-6.26-35.04%0.19
ILMN logoILMNIllumina, Inc.Product Competitor21.66B142.5826.16-0.78%19.43%32.84%0.94
PACB logoPACBPacific Biosciences of California, Inc.Product Competitor516.17M1.71-1.60-23.19%-325.8%-13.95%1.33
BRKR logoBRKRBruker CorporationProduct Competitor6.44B42.30-2822.08%-0.75%-1.11%0.81
TWST logoTWSTTwist Bioscience CorporationProduct Competitor3.71B59.53-45.7920.32%-19.85%-17.46%0.29
BEAM logoBEAMBeam Therapeutics Inc.Product Competitor3.32B32.33-39.92120.01%-57.24%-7.31%0.24

Compare SEER vs Peers

Seer, Inc. (SEER) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs QTRX

Most directly comparable listed peer for SEER.

Scale Benchmark

vs TMO

Larger-name benchmark to compare SEER against a more recognizable public peer.

Peer Set

Compare Top 5

vs QTRX, CDNA, NAUT, ILMN

SEER Income Statement

Seer, Inc. (SEER) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue0116K656K6.39M14.69M15.18M13.95M16.33M
Revenue Growth %--465.52%874.7%129.67%3.38%-8.13%14.49%
Cost of Goods Sold100K701K1.61M6.77M14.3M13.73M7.12M9.68M
COGS % of Revenue-604.31%244.82%105.85%97.39%90.46%51.01%-
Gross Profit
-100K▲ 0%
-585K▼ 485.0%
-950K▼ 62.4%
-374K▲ 60.6%
384K▲ 202.7%
1.45M▲ 277.3%
6.83M▲ 371.5%
6.65M▲ 0%
Gross Margin %--504.31%-144.82%-5.85%2.61%9.54%48.99%40.72%
Gross Profit Growth %--485%-62.39%60.63%202.67%277.34%371.5%-
Operating Expenses6.66M16.3M32.7M71.32M98.43M106.39M106.93M90.79M
OpEx % of Revenue-14050%4984.6%1115.45%670.26%700.77%766.71%-
Selling, General & Admin2.98M4.61M15.36M42.2M52.63M58.95M56.57M45.65M
SG&A % of Revenue-3970.69%2341.92%660.01%358.39%388.29%405.61%-
Research & Development3.68M11.69M17.34M29.12M45.8M47.44M50.59M45.14M
R&D % of Revenue-10079.31%2642.68%455.44%311.86%312.48%362.69%-
Other Operating Expenses000000-223K0
Operating Income
-6.76M▲ 0%
-16.88M▼ 149.8%
-33.65M▼ 99.3%
-71.7M▼ 113.1%
-98.04M▼ 36.7%
-104.94M▼ 7.0%
-100.1M▲ 4.6%
-84.15M▲ 0%
Operating Margin %--14554.31%-5129.42%-1121.3%-667.64%-691.23%-717.72%-515.41%
Operating Income Growth %--149.82%-99.31%-113.07%-36.75%-7.04%4.61%-
EBITDA-6.66M-16.18M-32.04M-68.13M-92.14M-99.36M-93.92M-76.47M
EBITDA Margin %--13950%-4884.6%-1065.58%-627.46%-654.49%-673.44%-468.42%
EBITDA Growth %--143.05%-98.02%-112.63%-35.24%-7.84%5.47%17.5%
D&A (Non-Cash Add-back)100K701K1.61M3.56M5.9M5.58M6.18M7.67M
EBIT-6.31M-16.03M-32.77M-71.17M-92.97M-86.28M-100.1M-79.08M
Net Interest Income451K845K883K304K4.6M17.76M16.67M12.54M
Interest Income451K850K883K326K4.6M17.76M16.67M12.54M
Interest Expense05K022K0000
Other Income/Expense451K845K874K527K5.08M18.66M13.6M5.07M
Pretax Income
-6.31M▲ 0%
-16.04M▼ 154.3%
-32.77M▼ 104.4%
-71.17M▼ 117.1%
-92.97M▼ 30.6%
-86.28M▲ 7.2%
-86.5M▼ 0.3%
-79.08M▲ 0%
Pretax Margin %--13825.86%-4996.19%-1113.06%-633.07%-568.28%-620.21%-484.36%
Income Tax00000098K271K
Effective Tax Rate %0%0%0%0%0%0%-0.11%-0.34%
Net Income
-6.31M▲ 0%
-16.04M▼ 154.3%
-32.77M▼ 104.4%
-71.17M▼ 117.1%
-92.97M▼ 30.6%
-86.28M▲ 7.2%
-86.6M▼ 0.4%
-79.35M▲ 0%
Net Margin %--13825.86%-4996.19%-1113.06%-633.07%-568.28%-620.91%-486.02%
Net Income Growth %--154.29%-104.36%-117.14%-30.63%7.2%-0.37%4%
Net Income (Continuing)-6.31M-16.04M-32.77M-71.17M-92.97M-86.28M-86.6M-79.35M
Discontinued Operations00000000
Minority Interest00000000
EPS (Diluted)
-0.29▲ 0%
-0.26▲ 10.3%
-0.51▼ 96.2%
-1.13▼ 121.6%
-1.42▼ 25.7%
-1.35▲ 4.9%
-1.39▼ 3.0%
-1.41▲ 0%
EPS Growth %-10.34%-96.15%-121.57%-25.66%4.93%-2.96%-3.08%
EPS (Basic)-0.29-0.26-0.51-1.13-1.42-1.35-1.39-
Diluted Shares Outstanding21.45M60.91M60.91M60.86M62.43M63.85M62.35M56.31M
Basic Shares Outstanding21.45M60.91M60.91M60.86M62.43M63.85M62.35M56.31M
Dividend Payout Ratio--------

SEER Balance Sheet

Seer, Inc. (SEER) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets31.21M86.81M433.13M411.7M434.98M330.51M253.32M214.36M
Cash & Short-Term Investments30.95M86.02M431.86M400.07M421.24M316.22M236.41M199.24M
Cash Only30.95M17.48M333.58M232.81M53.21M32.5M40.75M44.97M
Short-Term Investments068.53M98.28M167.26M368.03M283.73M195.66M154.26M
Accounts Receivable69K326K262K4.14M7.02M6.72M6.23M5.16M
Days Sales Outstanding-1.03K145.78236.56174.43161.46163.02125.5
Inventory00551K4.14M4.63M4.49M7.44M8.13M
Days Inventory Outstanding--125.23223.54118.09119.36381.47284.22
Other Current Assets00452K02.1M3.08M3.25M1.84M
Total Non-Current Assets2.48M6.43M9.19M127.44M52.95M105.76M113.27M94.25M
Property, Plant & Equipment2.36M5.69M8.44M33.23M46.41M47.37M41.37M36.55M
Fixed Asset Turnover-0.02x0.08x0.19x0.32x0.32x0.34x0.42x
Goodwill00000000
Intangible Assets00000000
Long-Term Investments00343K93.19M5.16M56.86M63.1M214.58M
Other Non-Current Assets124K743K407K1.02M1.38M1.53M8.8M26.44M
Total Assets
33.7M▲ 0%
93.24M▲ 176.7%
442.32M▲ 374.4%
539.14M▲ 21.9%
487.93M▼ 9.5%
436.27M▼ 10.6%
366.6M▼ 16.0%
308.61M▲ 0%
Asset Turnover-0.00x0.00x0.01x0.03x0.03x0.04x0.05x
Asset Growth %-176.7%374.41%21.89%-9.5%-10.59%-15.97%-73.88%
Total Current Liabilities3.69M3.81M8.09M13.42M12.58M13.22M15.33M15.04M
Accounts Payable2.63M701K2.12M3.79M2.1M1.37M4.62M4.26M
Days Payables Outstanding9.58K365480.68204.3453.736.41237.06150.9
Short-Term Debt000002.29M2.31M0
Deferred Revenue (Current)0175K250K376K133K206K408K1.85M
Other Current Liabilities344K1.6M2.86M4.73M6.35M2.73M1.54M6.06M
Current Ratio8.46x22.75x53.51x30.67x34.57x25.00x16.53x16.53x
Quick Ratio8.46x22.75x53.44x30.36x34.20x24.66x16.04x16.04x
Cash Conversion Cycle---209.68255.76238.83244.41307.43258.82
Total Non-Current Liabilities30K1.74M2.62M22.8M28.35M26.14M23.7M21.75M
Long-Term Debt00000000
Capital Lease Obligations00022.46M28.03M25.96M23.65M90.81M
Deferred Tax Liabilities00000000
Other Non-Current Liabilities30K1.74M2.62M341K320K179K48K109K
Total Liabilities3.72M5.56M10.71M36.22M40.94M39.37M39.03M36.79M
Total Debt00023.32M29.87M28.26M25.96M24.25M
Net Debt-30.95M-17.48M-333.58M-209.49M-23.33M-4.24M-14.79M-20.72M
Debt / Equity---0.05x0.07x0.07x0.08x0.08x
Debt / EBITDA--------0.32x
Net Debt / EBITDA-------0.27x
Interest Coverage--3376.60x--3258.91x----
Total Equity
29.98M▲ 0%
87.68M▲ 192.5%
431.61M▲ 392.3%
502.92M▲ 16.5%
446.99M▼ 11.1%
396.9M▼ 11.2%
327.57M▼ 17.5%
271.81M▲ 0%
Equity Growth %-192.51%392.26%16.52%-11.12%-11.21%-17.47%-78.49%
Book Value per Share1.401.447.098.267.166.225.254.83
Total Shareholders' Equity29.98M87.68M431.61M502.92M446.99M396.9M327.57M271.81M
Common Stock001K1K1K1K1K1K
Retained Earnings-6.55M-22.59M-55.36M-126.53M-219.5M-305.77M-392.37M-449.98M
Treasury Stock00000000
Accumulated OCI-31K24K54K-536K-1.25M-192K136K431K
Minority Interest00000000

SEER Cash Flow Statement

Seer, Inc. (SEER) cash flow — operating, investing & free cash flow history

Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-4.65M-13.07M-20.83M-46.35M-60.78M-59.06M-46.11M-46.11M
Operating CF Margin %--11269.83%-3175%-724.85%-413.89%-389.05%-330.6%-
Operating CF Growth %--181.08%-59.32%-122.52%-31.14%2.82%21.94%-20.76%
Net Income-6.31M-16.04M-32.77M-71.17M-92.97M-86.28M-86.6M-79.35M
Depreciation & Amortization31K701K1.61M2.56M3.94M5.58M6.18M6.21M
Stock-Based Compensation672K1.56M7.35M25.93M33.67M34.42M28.21M18.57M
Deferred Taxes0-259K01.2M0000
Other Non-Cash Items549K5K271K1M1.66M-10.07M6.25M9.73M
Working Capital Changes953K961K2.72M-5.87M-7.09M-2.72M-144K-257K
Change in Receivables-69K-257K64K-2.5M-2.87M302K487K1.29M
Change in Inventory0257K-551K-3.59M-1.59M-1.95M-2.67M-3.11M
Change in Payables323K218K912K1.6M-1.55M-987K3.35M3.48M
Cash from Investing-168K-72.38M-34.56M-170.88M-122.72M37.9M65.86M64.42M
Capital Expenditures-168K-4.13M-4.53M-6.92M-10.27M-7.31M-3.58M-969K
CapEx % of Revenue-3561.21%691.16%108.26%69.9%48.14%25.7%-
Acquisitions068.25M-50K163.96M000107K
Investments--------
Other Investing0-68.25M0-163.96M170K0343K882K
Cash from Financing29.95M72.33M371.49M116.63M3.89M452K-11.49M-11.97M
Debt Issued (Net)00000000
Equity Issued (Net)01000K1000K1000K-20K-13K-1000K-3.67M
Dividends Paid00000000
Share Repurchases0-6K-13K-35K-20K-13K-11.82M-11.57M
Other Financing29.95M406K1.26M13.71M3.91M465K321K-630K
Net Change in Cash
25.13M▲ 0%
-13.13M▼ 152.2%
316.1M▲ 2508.4%
-100.59M▼ 131.8%
-179.6M▼ 78.5%
-20.71M▲ 88.5%
8.25M▲ 139.9%
7.35M▲ 0%
Free Cash Flow
-4.82M▲ 0%
-17.2M▼ 257.0%
-25.36M▼ 47.4%
-53.27M▼ 110.0%
-71.05M▼ 33.4%
-66.37M▲ 6.6%
-49.69M▲ 25.1%
-46.07M▲ 0%
FCF Margin %--14831.03%-3866.16%-833.11%-483.79%-437.19%-356.3%-282.17%
FCF Growth %--257%-47.42%-110.03%-33.37%6.57%25.13%9.32%
FCF per Share-0.22-0.28-0.42-0.88-1.14-1.04-0.80-0.80
FCF Conversion (FCF/Net Income)0.74x0.82x0.64x0.65x0.65x0.68x0.53x0.58x
Interest Paid00000000
Taxes Paid000645K232K0154K0

SEER Key Ratios

Seer, Inc. (SEER) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201920202021202220232024TTM
Return on Equity (ROE)-27.26%-12.62%-15.23%-19.57%-20.45%-23.91%-29.19%
Return on Invested Capital (ROIC)-36.59%-30%-27.47%-20.51%-19.28%-21.28%-21.28%
Gross Margin-504.31%-144.82%-5.85%2.61%9.54%48.99%40.72%
Net Margin-13825.86%-4996.19%-1113.06%-633.07%-568.28%-620.91%-486.02%
Debt / Equity--0.05x0.07x0.07x0.08x0.08x
Interest Coverage-3376.60x--3258.91x----
FCF Conversion0.82x0.64x0.65x0.65x0.68x0.53x0.58x
Revenue Growth-465.52%874.7%129.67%3.38%-8.13%14.49%

SEER SEC Filings & Documents

Seer, Inc. (SEER) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 13, 2026·SEC

Material company update

Mar 30, 2026·SEC

Material company update

Mar 16, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Mar 4, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 13, 2025·SEC

SEER Frequently Asked Questions

Seer, Inc. (SEER) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Seer, Inc. (SEER) reported $16.3M in revenue for fiscal year 2024.

Seer, Inc. (SEER) saw revenue decline by 8.1% over the past year.

Seer, Inc. (SEER) reported a net loss of $79.3M for fiscal year 2024.

Dividend & Returns

Seer, Inc. (SEER) has a return on equity (ROE) of -23.9%. Negative ROE indicates the company is unprofitable.

Seer, Inc. (SEER) had negative free cash flow of $46.1M in fiscal year 2024, likely due to heavy capital investments.

Explore More SEER

Seer, Inc. (SEER) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.